Avastin Receives European Approval for Ovarian Cancer Treatment

by Kathy Jones on  December 26, 2011 at 9:26 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

Swiss drug maker Roche has revealed that the European Commission has approved the use of Avastin for treating women with early and advanced form of ovarian cancer.
 Avastin Receives European Approval for Ovarian Cancer Treatment
Avastin Receives European Approval for Ovarian Cancer Treatment

The company said that the drug has been approved for the treatment in combination with standard chemotherapy. The approval comes after two late stage studies found Avastin, when used in combination with chemotherapy, to increase the time period without the disease getting worse compared to only chemotherapy being used.

Announcing the approval, the company's Chief Medical Officer Hal Barron said, "Today's approval of Avastin marks the first major treatment advance in newly diagnosed ovarian cancer in 15 years. This is the fifth tumor type for which Avastin has been approved in Europe, making it one of few biologic drugs indicated for multiple cancers."



Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Ovarian Cancer Cancer and Homeopathy Cancer Facts Cancer Tattoos A Body Art Meigs Syndrome Ovarian Pain Premature Ovarian Failure Common Lifestyle Habits that Cause Diseases Health Benefits of Dandelion Plant 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive